Loading...
OTCM
MYRX
Market cap6kUSD
Jul 16, Last price  
0.00USD
1D
0.00%
1Q
-97.14%
Jan 2017
-99.58%
IPO
-100.00%
Name

Myrexis Inc

Chart & Performance

D1W1MN
OTCM:MYRX chart
No data to show
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-67.94%
Revenues
0k
110,774,0005,456,00090,000185,00000
Net income
-12m
L-62.76%
-34,369,000-58,136,000-46,951,000-38,708,000-31,209,000-11,621,000
CFO
-13m
L-53.29%
12,180,000-60,682,000-40,368,000-33,455,000-27,774,000-12,972,000
Dividend
Feb 19, 20132.86 USD/sh

Profile

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
URL
https://myrexis.com/
IPO date
Jun 12, 2009
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

No data to show